-+ 0.00%
-+ 0.00%
-+ 0.00%

Chardan Capital Maintains Buy on Metagenomi, Lowers Price Target to $11

Benzinga·08/15/2025 21:04:22
Listen to the news
Chardan Capital analyst Geulah Livshits maintains Metagenomi (NASDAQ:MGX) with a Buy and lowers the price target from $12 to $11.